Skip to main content
British Journal of Cancer logoLink to British Journal of Cancer
. 1979 Apr;39(4):391–397. doi: 10.1038/bjc.1979.71

Cell-cycle inhibitory effects of the mitotic inhibitor NY 3170 on human cells in vitro.

E Wibe, R Oftebro, S G Laland, E O Pettersen, T Lindmo
PMCID: PMC2009934  PMID: 444397

Abstract

Effects of the mitotic inhibitor NY 3170 (1-propargyl-5-chloropyrimidin-2-one) on cell-cycle kinetics of NHIK 3025 cells were studied by means of time-lapse microcinematography, pulsed incorporation of [3H] thymidine, flow cytometry, and mitotic index. All the experiments were performed with cells synchronized by mitotic selection. Mitotic inhibition as well as inhibition in interphase was examined. The small fraction of cells able to escape mitotic arrest at 0.2mM NY 3170 had spent about 12 h in metaphase. The metaphase block was complete at 0.3 mM. For comparison, complete metaphase arrest of NHIK 3025 cells was reached at 8 mM after treatment with the parent substance NY 3000 (5-chloropyrimidin-2-one, previously reported). At 0.3mM NY 3170 interphase was also considerably prolonged. All stages of interphase were prolonged, in contrast to the interphase prolongation after treatment with high concentrations of the mitotic inhibitors vincristine and vinblastine, which occurs in G2. It was shown that the presence of NY 3170 during mitosis is a necessary and sufficient condition for metaphase arrest, thus demonstrating that metaphase arrest is not dependent on some preceding event in interphase.

Full text

PDF
391

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Crissman H. A., Tobey R. A. Cell-cycle analysis in 20 minutes. Science. 1974 Jun 21;184(4143):1297–1298. doi: 10.1126/science.184.4143.1297. [DOI] [PubMed] [Google Scholar]
  2. Lindmo T., Steen H. B. Flow cytometric measurement of the polarization of fluorescence from intracellular fluorescein in mammalian cells. Biophys J. 1977 May;18(2):173–187. doi: 10.1016/S0006-3495(77)85606-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Madoc-Jones H., Mauro F. Interphase action of vinblastine and vincristine: differences in their lethal action through the mitotic cycle of cultured mammalian cells. J Cell Physiol. 1968 Dec;72(3):185–196. doi: 10.1002/jcp.1040720306. [DOI] [PubMed] [Google Scholar]
  4. Oftebro R., Grimmer O., Oyen T. B., Laland S. G. 5-Fluoropyrimidin-2-one, a new metaphase arresting agent. Biochem Pharmacol. 1972 Sep 15;21(18):2451–2456. doi: 10.1016/0006-2952(72)90415-7. [DOI] [PubMed] [Google Scholar]
  5. PUCK T. T., CIECIURA S. J., FISHER H. W. Clonal growth in vitro of human cells with fibroblastic morphology; comparison of growth and genetic characteristics of single epithelioid and fibroblast-like cells from a variety of human organs. J Exp Med. 1957 Jul 1;106(1):145–158. doi: 10.1084/jem.106.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Pettersen E. O., Bakke O., Lindmo T., Oftebro R. Cell cycle characteristics of synchronized and asynchronous populations of human cells and effect of cooling of selected mitotic cells. Cell Tissue Kinet. 1977 Nov;10(6):511–522. doi: 10.1111/j.1365-2184.1977.tb00309.x. [DOI] [PubMed] [Google Scholar]
  7. Wibe E., Oftebro R., Christensen T., Laland S. G., Pettersen E. O., Lindmo T. Inhibitory effects of the new mitotic inhibitor 5-chloropyrimidin-2-one and of vincristine on human cells in vitro. Cancer Res. 1978 Mar;38(3):560–565. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES